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TO THE EDITOR
Dengue virus (DENV) is at present the
most important emerging arbovirus.
The incidence of DENV infection has
grown markedly around the world in
recent decades because of expanding
geographic distribution of the virus and
their mosquito vectors, Aedes (Ae.)
aegypti and Ae. albopictus. DENV is
an enveloped positive single-stranded
RNA virus that belongs to the Flavivir-
idae family. DENV can cause dengue
hemorrhagic fever and dengue shock
syndrome. Vector-mediated transmis-
sion of DENV is initiated when a
blood-feeding female Ae. mosquito
injects saliva, together with the virus,
into the skin of its mammalian host.
Mosquito saliva contains a repertoire
of bioactive components that modulate
the host’s hemostasis and immune
response, thus facilitating blood feed-
ing and pathogen transmission (re-
views in Schneider and Higgs (2008)
and Ribeiro et al. (2010)). It has been
demonstrated that Ae. aegypyi salivary
proteins are immmunosuppressive
and are associated with an increase
of West Nile virus in the skin (Schnei-
der et al., 2010). Moreover, a recent
comparison of cutaneous cytokines
elicited in mice by Chikungunya
virus revealed a reorientation of the
host’s protective TH1 to a TH2 type
immune response by the presence of
the Ae aegypti saliva (Thangamani
et al., 2010). Taken together, these
and other results obtained from
studies in several experimental disease
models, using various arthropod-borne
viruses, demonstrate that saliva is
associated with an increase in virus
pathogenicity (review in Schneider and
Higgs (2008)).
During blood feeding, an infected
mosquito transmits virus in saliva that
is secreted predominantly in the extra-
vascular regions of the uppermost
layer of skin, the epidermis, which
consists primarily of keratinocytes
(Limon-Flores et al., 2005). Whereas
dendritic cells have long been consid-
ered to be the main target of DENV
(Halstead and O’Rourke, 1977), we
have recently demonstrated that hu-
man keratinocytes are permissive to
DENV infection as well. DENV repli-
cation in infected primary human
keratinocytes was found to lead to
activation of antiviral innate immune
responses by activating signaling path-
ways that converge into secretion of
antimicrobial peptides (AMPs) and
IFNs (Surasombatpattana et al., 2011).
Therefore, we investigated the effect of
Ae. aegypti salivary gland extract (SGE) on
DENV infection in human keratinocytes.
Human primary keratinocytes were
infected with DENV in the presence or
absence of Ae. aegypti SGE obtained
from a single pair of salivary glands. At
6 and 24 hours post infection (h.p.i.),
intracellular viral mRNA levels were
quantified by real-time PCR (Figure 1).
The expression levels of DENV tran-
scripts in the infected keratinocytes
were increased in the presence of
SGE, as compared with DENV infec-
tion alone, although not detected
in mock-infected cells. The results
furthermore show that, at 6 h.p.i., the
presence of SGE during the infection
of keratinocytes with DENV strongly
downregulated the expression of human
Abbreviations: Ae., Aedes; AMP, antimicrobial peptide; DENV, dengue virus; h.p.i., hours post infection;
HSV, herpes simplex virus; SGE, salivary gland extraction; SOD2, superoxide dismutase 2
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b-defensin 3 (Figure 2a). This is in
agreement with results obtained with
tick saliva proteins that were recently
reported to inhibit AMP production
(Marchal et al., 2011). AMPs provide
the epithelium with anti-infective de-
fenses against bacteria, fungi, protozoa,
and viruses. In the skin, AMPs are
produced mainly by epidermal kerati-
nocytes, either constitutively or in an
inducible manner. Defensins have a
dual role in antiviral activity, which is
mediated directly through interaction
with viral envelopes, possibly in a
manner similar to their antibacterial
activity, and indirectly through interac-
tions with potential target cells. These
defensin–cell interactions are complex
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Figure 1. Ae. aegypti salivary gland extract enhances dengue virus (DENV) replication in infected
keratinocytes. Primary human keratinocytes were infected with DENV at a multiplicity of infection of 1
in the presence or absence of salivary gland extract obtained from one salivary gland pair (1SGP) of Ae.
aegypti. After 6 and 24 hours, intracellular viral RNA was analyzed by real-time quantitative RT-PCR.
Results are expressed as viral RNA copies per microliter in DENV-infected keratinocytes in the presence
or absence of SGP. Data are representative of three independent experiments, each performed in
duplicate, ±standard error of the mean. Wilcoxon–Mann–Whitney test was used to analyze the
difference between sets of data. A value of Po0.05 was considered significant. *P-values o0.05.
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Figure 2. mRNA expression of antimicrobial peptides, IFNs, and SOD2 in dengue virus (DENV)-infected keratinocytes. Cells were exposed to DENV at a
multiplicity of infection of 1 in the presence or absence of Ae. aegypti salivary gland extract (SGE) obtained from one salivary gland pair (1SGP). mRNA
expression of (a) b-defensin 3, (b) LL-37, (c) Elafin, (d) S100A7, (e) IFN-a, (f) IFN-b, (g) IFN-g, and (h) SOD2 was analyzed by real-time quantitative RT-PCR at the
indicated times. Results are expressed as fold induction of transcripts in DENV-infected keratinocytes in the presence or absence of SGE, relative to those in
mock-infected cells. Wilcoxon–Mann–Whitney test was used to analyze the difference between sets of data. A value of Po0.05 was considered significant.
*P-values o0.05.
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and possibly mediated by binding to
cell-surface glycoproteins and/or inter-
fering with cell-signaling pathways that
are required for viral replication (Klotman
and Chang, 2006). Interestingly, recent
studies on the activity of defensins
against herpes simplex virus (HSV)
show that prevention of viral entry is
another important mechanism of pep-
tide inhibitory action against these
enveloped viruses (Gordon et al.,
2005). At 6 h.p.i., saliva was found to
also strongly suppress the expres-
sion of LL-37, the only human member
of the cathelicidin family of AMP, in
DENV-infected keratinocytes (Figure
2b). LL-37 recruits mast cells, neutro-
phils, monocytes, and T cells to in-
flamed skin following binding to the
formyl peptide receptor–like 1 (Niyon-
saba et al., 2002) and is able to inhibit
vaccinia virus replication, which has
been attributed to its direct disruptive
action on the viral envelope, especially
through permeabilization of the external
lipid membrane (Klotman and Chang,
2006). This mechanism has been pre-
viously proposed for all cationic pep-
tides against HSV-1 and other enveloped
viruses, as well as against bacteria and
fungi. Moreover, expression of tran-
scripts for S100A7 and PI3, the gene
encoding Elafin, was also significantly
suppressed in the presence of Ae.
aegypti saliva at 6 h.p.i. (Figure 2c and
d). S100A7 is an additional keratino-
cyte-derived AMP that preferentially
kills E. coli and functions as a transglu-
taminase substrate/cornified envelope
precursor transduction protein, chemo-
kine, and antibacterial protein in
normal epidermis. It is important to
note that the function of S100A7 may
differ between normal and stressed
keratinocytes. Active export or cell
breakdown may facilitate the release
of S100A7, allowing it to act as a
chemokine. In this context, S100A7
expression level was reported to be
controlled by cytokines such as IFNs
(Eckert and Lee, 2006). Elafin is an
antimicrobial and anti-inflammatory
molecule that inhibits neutrophil elas-
tase and proteinase 3. It is noteworthy
that recombinant Elafin inhibits HIV-1
in a dose-dependent manner (Taborda-
Vanegas et al., 2011). IFNs are involved
in antiviral defense, cell growth regula-
tion, and immune activation. DENV
infection in keratinocyte is a potent
inducer of IFNs (Surasombatpattana
et al., 2011). Interestingly, IFN expres-
sion was significantly suppressed in the
presence of SGE at 24 h.p.i. (Figure
2e–g), corroborating previously pub-
lished reports in the literature (Schnei-
der and Higgs, 2008; Schneider et al.,
2010). Finally, the expression level of
superoxide dismutase 2 (SOD2), a gene
known to be involved in the establish-
ment of the IFN-induced antiviral re-
sponse (Pottathil et al., 1981), was
upregulated in DENV-infected human
keratinocytes at both 6 and 24 h.p.i.
(Figure 2h). However, the expression
level of SOD2 was not affected by the
presence of SGE. To our knowledge,
this is the first study showing the
importance of Ae. aegypti saliva in the
earliest events of DENV transmission via
the inhibition of AMP and IFNs secre-
tion by infected keratinocytes.
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